Clinical Trials Browser

Interventional × Epirubicin × Genitourinary × Clear all

NCT07424287 2026-02-20

A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC

Phase 3 Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT05024734 2025-03-11

GAIN INST

Phase 2 Recruiting

Urinary Bladder Neoplasms

NCT06309732 2024-03-13

GAMEC-II

Phase 2 Completed

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms

NCT06227065 2024-01-26

POLO

Phase 2 Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT05547516 2022-09-21

BL-PDT-RCT

Phase NA Unknown

Non-Muscle Invasive Bladder Neoplasms

NCT04490993 2022-02-22

ACCRUE

Phase 3 Unknown

Non-Muscle Invasive Bladder Neoplasms

NCT04736394 2022-02-22

ASCERTAIN

Phase 3 Unknown

Non-Muscle Invasive Bladder Neoplasms

NCT05146635 2022-01-11

Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial

Phase NA Unknown

Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT03892330 2019-03-27

Combination Therapy of Anthracyclines for Children With Nephroblastoma

Phase 4 Not yet recruiting

Wilms Tumor

NCT00096304 2018-04-10

Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer

Phase 1 Terminated

Prostatic Neoplasms

NCT02214602 2018-03-22

NMIBCIVT

Phase 4 Completed

Non-Muscle Invasive Bladder Neoplasms

NCT02760953 2017-10-19

TURBt With Adjuvant Cryoablation to Treat Bladder Cancer

Phase NA Unknown

Urinary Bladder Neoplasms

NCT00003852 2016-06-23

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors

Phase 2 Terminated

GenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Testicular Neoplasms

NCT02547350 2015-09-11

Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas

Phase 2 Unknown

Upper Tract Urothelial Carcinoma

NCT01094964 2013-08-12

Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer

Phase 3 Unknown

Urinary Bladder Neoplasms

NCT00231582 2011-02-25

High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II

Phase 2 Completed

Testicular Neoplasms

NCT00218205 2005-09-22

A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms